Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Farmers Insurance
Dow
Harvard Business School
UBS
Healthtrust
McKesson
US Department of Justice
Deloitte

Generated: May 21, 2018

DrugPatentWatch Database Preview

Glenmark Generics Company Profile

« Back to Dashboard

What is the competitive landscape for GLENMARK GENERICS, and what generic and branded alternatives to GLENMARK GENERICS drugs are available?

GLENMARK GENERICS has sixty-eight approved drugs.

There are three tentative approvals on GLENMARK GENERICS drugs.

Summary for Glenmark Generics
US Patents:0
Tradenames:59
Ingredients:54
NDAs:68
Patent Litigation for Glenmark Generics: See patent lawsuits for Glenmark Generics

Drugs and US Patents for Glenmark Generics

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Generics TOPIRAMATE topiramate TABLET;ORAL 077627-004 Mar 27, 2009 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Glenmark Generics MOEXIPRIL HYDROCHLORIDE moexipril hydrochloride TABLET;ORAL 090416-001 Mar 30, 2010 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Glenmark Generics FELODIPINE felodipine TABLET, EXTENDED RELEASE;ORAL 090365-002 Dec 17, 2010 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Glenmark Generics TROSPIUM CHLORIDE trospium chloride TABLET;ORAL 091575-001 Aug 13, 2010 AB RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for GLENMARK GENERICS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Colorcon
Baxter
Cipla
Federal Trade Commission
Dow
AstraZeneca
Express Scripts
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.